Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Sjöwall

Showing results (11-20 of 170) with videos related to

Pageof 17
Sort By:
Arthritis Research & Therapy|January 11, 2015
Application of the 2012 Systemic Lupus International Collaborating Clinics classification criteria to patients in a regional Swedish systemic lupus erythematosus registerAnna Ighe, Örjan Dahlström, Thomas Skogh, et al.
Frontiers in Medicine|March 18, 2021
Longitudinal Analysis of Anti-cardiolipin and Anti-β2-glycoprotein-I Antibodies in Recent-Onset Systemic Lupus Erythematosus: A Prospective Study in Swedish PatientsMartina Frodlund, Tomas Walhelm, Charlotte Dahle, et al.
Frontiers in Medicine|May 13, 2021
Successful Treatment of AA Amyloidosis in Ankylosing Spondylitis Using Tocilizumab: Report of Two Cases and Review of the LiteraturePer Eriksson, Johan Mölne, Lina Wirestam, et al.
Rheumatology (Oxford, England)|May 25, 2023
Belimumab and antimalarials combined against renal flares in patients treated for extra-renal systemic lupus erythematosus: results from 4 phase III clinical trialsAlvaro Gomez, Sandra Jägerback, Christopher Sjöwall, et al.
Rheumatology International|March 19, 2024
The prevalence of neutropenia and association with infections in patients with systemic lupus erythematosus: a Swedish single-center study conducted over 14 yearsMuna Saleh, Johanna Sjöwall, Marcus Bendtsen, et al.
Frontiers in Immunology|June 12, 2023
Clinical experience and safety of Janus kinase inhibitors in giant cell arteritis: a retrospective case series from SwedenPer Eriksson, Oliver Skoglund, Cecilia Hemgren, et al.
Frontiers in Medicine|November 9, 2020
High-Frequency Ultrasound of Multiple Arterial Areas Reveals Increased Intima Media Thickness, Vessel Wall Appearance, and Atherosclerotic Plaques in Systemic Lupus ErythematosusChristina Svensson, Per Eriksson, Helene Zachrisson, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 7, 2013
Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosusHelena Enocsson, Jonas Wetterö, Thomas Skogh, et al.
BMC Musculoskeletal Disorders|August 13, 2015
Quality of life and acquired organ damage are intimately related to activity limitations in patients with systemic lupus erythematosusMathilda Björk, Örjan Dahlström, Jonas Wetterö, et al.
Journal of Immunology Research|September 25, 2018
Two-Parametric Immunological Score Development for Assessing Renal Involvement and Disease Activity in Systemic Lupus ErythematosusChristopher Sjöwall, Chelsea Bentow, Mary Ann Aure, et al.
Pageof 17

Showing results (11-20 of 170) with videos related to

Sort By:
Pageof 17
Arthritis Research & Therapy|January 11, 2015
Application of the 2012 Systemic Lupus International Collaborating Clinics classification criteria to patients in a regional Swedish systemic lupus erythematosus registerAnna Ighe, Örjan Dahlström, Thomas Skogh, et al.
Frontiers in Medicine|March 18, 2021
Longitudinal Analysis of Anti-cardiolipin and Anti-β2-glycoprotein-I Antibodies in Recent-Onset Systemic Lupus Erythematosus: A Prospective Study in Swedish PatientsMartina Frodlund, Tomas Walhelm, Charlotte Dahle, et al.
Frontiers in Medicine|May 13, 2021
Successful Treatment of AA Amyloidosis in Ankylosing Spondylitis Using Tocilizumab: Report of Two Cases and Review of the LiteraturePer Eriksson, Johan Mölne, Lina Wirestam, et al.
Rheumatology (Oxford, England)|May 25, 2023
Belimumab and antimalarials combined against renal flares in patients treated for extra-renal systemic lupus erythematosus: results from 4 phase III clinical trialsAlvaro Gomez, Sandra Jägerback, Christopher Sjöwall, et al.
Rheumatology International|March 19, 2024
The prevalence of neutropenia and association with infections in patients with systemic lupus erythematosus: a Swedish single-center study conducted over 14 yearsMuna Saleh, Johanna Sjöwall, Marcus Bendtsen, et al.
Frontiers in Immunology|June 12, 2023
Clinical experience and safety of Janus kinase inhibitors in giant cell arteritis: a retrospective case series from SwedenPer Eriksson, Oliver Skoglund, Cecilia Hemgren, et al.
Frontiers in Medicine|November 9, 2020
High-Frequency Ultrasound of Multiple Arterial Areas Reveals Increased Intima Media Thickness, Vessel Wall Appearance, and Atherosclerotic Plaques in Systemic Lupus ErythematosusChristina Svensson, Per Eriksson, Helene Zachrisson, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 7, 2013
Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosusHelena Enocsson, Jonas Wetterö, Thomas Skogh, et al.
BMC Musculoskeletal Disorders|August 13, 2015
Quality of life and acquired organ damage are intimately related to activity limitations in patients with systemic lupus erythematosusMathilda Björk, Örjan Dahlström, Jonas Wetterö, et al.
Journal of Immunology Research|September 25, 2018
Two-Parametric Immunological Score Development for Assessing Renal Involvement and Disease Activity in Systemic Lupus ErythematosusChristopher Sjöwall, Chelsea Bentow, Mary Ann Aure, et al.
Pageof 17